Literature DB >> 2777269

Chronic non-neurological toxicity from volatile substance abuse.

R Marjot1, A A McLeod.   

Abstract

1. Most of the evidence for chronic non-neurological toxicity from volatile substance abuse is derived from case reports. 2. Factors important in assessing these reports are the marked variations in exposure conditions and in the composition of the products abused. 3. In a young and otherwise healthy population, any chronic organ toxicity arising from VSA has to be gross in order to become clinically apparent. This may partially explain the relatively low incidence of reporting. 4. Toluene and the chlorinated hydrocarbons 1,1,1-trichloroethane and trichloroethylene can cause permanent damage to the kidney, liver, heart and lung, in certain volatile substance abusers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777269     DOI: 10.1177/096032718900800408

Source DB:  PubMed          Journal:  Hum Toxicol        ISSN: 0144-5952


  14 in total

1.  Review of toluene action: clinical evidence, animal studies and molecular targets.

Authors:  Silvia L Cruz; María Teresa Rivera-García; John J Woodward
Journal:  J Drug Alcohol Res       Date:  2014

2.  Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes.

Authors:  S L Cruz; R L Balster; J J Woodward
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 3.  Solvent abuse.

Authors:  C H Ashton
Journal:  BMJ       Date:  1990-01-20

Review 4.  Inhalant abuse among adolescents: neurobiological considerations.

Authors:  D I Lubman; M Yücel; A J Lawrence
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

5.  Inhalant abuse.

Authors:  L Baydala
Journal:  Paediatr Child Health       Date:  2010-09       Impact factor: 2.253

6.  Blue-yellow dyschromatopsia in toluene-exposed workers.

Authors:  Axel Muttray; Volkmar Wolters; Dirk-Matthias Rose
Journal:  Int Arch Occup Environ Health       Date:  2019-01-25       Impact factor: 3.015

7.  Binge toluene exposure in pregnancy and pre-weaning developmental consequences in rats.

Authors:  Scott E Bowen; John H Hannigan
Journal:  Neurotoxicol Teratol       Date:  2013-04-15       Impact factor: 3.763

Review 8.  An introduction to the clinical toxicology of volatile substances.

Authors:  R J Flanagan; M Ruprah; T J Meredith; J D Ramsey
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

9.  Decreased sensitivity in adolescent vs. adult rats to the locomotor activating effects of toluene.

Authors:  Scott E Bowen; Jonathan D Charlesworth; Mary E Tokarz; M Jerry Wright; Jenny L Wiley
Journal:  Neurotoxicol Teratol       Date:  2007-08-17       Impact factor: 3.763

10.  Increased risk for hepatitis C associated with solvent use among Canadian Aboriginal injection drug users.

Authors:  Souradet Y Shaw; Kathleen N Deering; Ann M Jolly; John L Wylie
Journal:  Harm Reduct J       Date:  2010-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.